You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 12, 2025

Drug Price Trends for IMIPRAMINE PAMOATE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for IMIPRAMINE PAMOATE

Average Pharmacy Cost for IMIPRAMINE PAMOATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMIPRAMINE PAMOATE 75 MG CAP 68180-0314-06 4.10151 EACH 2025-01-22
IMIPRAMINE PAMOATE 150 MG CAP 00054-0276-13 3.71027 EACH 2025-01-22
IMIPRAMINE PAMOATE 150 MG CAP 68180-0317-06 3.71027 EACH 2025-01-22
IMIPRAMINE PAMOATE 100 MG CAP 00054-0274-13 4.24230 EACH 2025-01-22
IMIPRAMINE PAMOATE 100 MG CAP 68180-0315-06 4.24230 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Imipramine Pamoate

Introduction to Imipramine Pamoate

Imipramine pamoate, marketed under the brand name Tofranil-PM, is a tricyclic antidepressant used primarily for the treatment of depression. It is available in various strengths, including 75 mg, 100 mg, 125 mg, and 150 mg capsules[1][4].

Market Demand and Usage

Imipramine pamoate is prescribed for the relief of symptoms of depression, particularly endogenous depression. The drug has been in use for several decades and remains a viable option for patients who do not respond to newer antidepressants or have specific clinical needs that make tricyclic antidepressants more suitable.

Pricing Overview

The cost of imipramine pamoate can vary significantly depending on the dosage, form, and pharmacy. Here are some current price ranges:

  • Oral Capsules:

    • 75 mg: Approximately $364.72 for 30 capsules, or $12.16 per unit[2].
    • 100 mg: Approximately $376.22 for 30 capsules, or $12.54 per unit[2].
    • 125 mg: Approximately $439.37 for 30 capsules, with a range of $14.65 to $21.86 per unit[2].
    • 150 mg: Approximately $186.51 for 30 capsules, or $6.22 per unit[2].
  • Oral Tablets:

    • 10 mg: Approximately $22.39 for 100 tablets, or $0.22 per unit[2].
    • 25 mg: Approximately $29.71 for 100 tablets, with a range of $0.30 to $0.54 per unit[2].
    • 50 mg: Approximately $36.76 for 100 tablets, with a range of $0.37 to $0.46 per unit[2].

Factors Influencing Pricing

Several factors can influence the pricing of imipramine pamoate:

Generic Availability

Imipramine pamoate is available in generic form, which generally reduces the cost compared to brand-name medications. The generic availability has helped in making the drug more accessible to a wider patient population[4].

Pharmacy and Location

Prices can vary significantly depending on the pharmacy and location. Using discount cards or shopping at different pharmacies can result in lower costs[2].

Stock Shortages

Stock shortages and other supply chain issues can lead to price fluctuations. Consumers should expect to pay the lower price when there is a range of pricing, but guarantees cannot be made due to these variables[2].

Drug Price Inflation

According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% in 2025. This inflation rate can impact the pricing of imipramine pamoate, although it may not be as significantly affected as newer, high-cost medications like GLP-1 agents[3].

Cost-Effective Preparation Methods

Efforts to reduce the cost of imipramine pamoate include the development of simpler and more cost-effective preparation methods. For instance, a one-pot preparation method with high yield and purity can make the compound more economically viable[5].

Patient Assistance Programs

Patient assistance programs and discount cards can significantly reduce the cost of imipramine pamoate. For example, the Drugs.com Discount Card can save patients up to 80% or more off the cost of prescription medicines[2].

Market Trends and Projections

  • Increasing Demand: Despite the availability of newer antidepressants, imipramine pamoate remains a treatment option for certain patient groups, ensuring a steady demand.
  • Price Stability: While general drug price inflation is expected, the prices of established generic medications like imipramine pamoate are likely to remain relatively stable compared to newer, high-cost therapies.
  • Cost Management: Healthcare providers and patients are increasingly looking for cost-effective treatments. The availability of generic imipramine pamoate and patient assistance programs will continue to play a crucial role in managing costs.

Conclusion

Imipramine pamoate is a well-established tricyclic antidepressant with a stable market presence. While prices can vary, the availability of generic forms and patient assistance programs helps in keeping the costs manageable. As the pharmaceutical market continues to evolve, the pricing of imipramine pamoate is expected to remain relatively stable, making it a viable treatment option for patients with depression.

Key Takeaways

  • Imipramine pamoate is used primarily for treating depression.
  • Prices vary by dosage and pharmacy, with generic forms generally being more cost-effective.
  • Patient assistance programs and discount cards can significantly reduce costs.
  • Drug price inflation is projected at 3.81% in 2025, but its impact on imipramine pamoate is expected to be minimal.
  • Cost-effective preparation methods are being developed to reduce production costs.

FAQs

What is imipramine pamoate used for?

Imipramine pamoate is used primarily for the relief of symptoms of depression, particularly endogenous depression[4].

How much does imipramine pamoate cost?

The cost of imipramine pamoate varies by dosage and pharmacy. For example, a 30-day supply of 75 mg capsules can cost around $364.72[2].

Is imipramine pamoate available in generic form?

Yes, imipramine pamoate is available in generic form, which generally reduces the cost compared to brand-name medications[4].

What factors influence the pricing of imipramine pamoate?

Factors influencing pricing include generic availability, pharmacy and location, stock shortages, and patient assistance programs[2].

How does drug price inflation affect imipramine pamoate?

While drug price inflation is projected at 3.81% in 2025, its impact on imipramine pamoate is expected to be minimal compared to newer, high-cost medications[3].

Are there any cost-effective preparation methods for imipramine pamoate?

Yes, there are efforts to develop simpler and more cost-effective preparation methods, such as a one-pot preparation method with high yield and purity[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.